Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactor™. Part I. Effect of the cell density on the process

Abstract

High cell density perfusion process of antibody producing CHO cells was developed in disposable WAVE Bioreactor™ using external hollow fiber filter as cell separation device. Both “classical” tangential flow filtration (TFF) and alternating tangential flow system (ATF) equipment were used and compared. Consistency of both TFF‐ and ATF‐based cultures was shown at 20–35 × 10 6 cells/mL density stabilized by cell bleeds. To minimize the nutrients deprivation and by‐product accumulation, a perfusion rate correlated to the cell density was applied. The cells were maintained by cell bleeds at density 0.9–1.3 × 10 8 cells/mL in growing state and at high viability for more than 2 weeks. Finally, with the present settings, maximal cell densities of 2.14 × 10 8 cells/mL, achieved for the first time in a wave‐induced bioreactor, and 1.32 × 10 8 cells/mL were reached using TFF and ATF systems, respectively. Using TFF, the cell density was limited by the membrane capacity for the encountered high viscosity and by the pCO 2 level. Using ATF, the cell density was limited by the vacuum capacity failing to pull the highly viscous fluid. Thus, the TFF system allowed reaching higher cell densities. The TFF inlet pressure was highly correlated to the viscosity leading to the development of a model of this pressure, which is a useful tool for hollow fiber design of TFF and ATF. At very high cell density, the viscosity introduced physical limitations. This led us to recommend cell densities under 1.46 × 10 8 cell/mL based on the analysis of the theoretical distance between the cells for the present cell line. © 2013 American Institute of Chemical Engineers Biotechnol. Prog ., 29:754–767, 2013

Shown for reading. Its publisher allows quoting it, not republishing it.

References 43

1. 1.

   Chu L, Robinson DK. Industrial choices for protein production by large-scale cell culture. Curr Opin Biotechnol. 2001;12:180-187.

   Not in our library10.1016/s0958-1669(00)00197-x

2. 2.

   Ryll T, Dutina G, Reyes A, Gunson J, Krummen L, Etcheverry T. Performance of small-scale CHO perfusion cultures using an acoustic cell filtration device for cell retention: characterization of separation efficiency and impact of perfusion on product quality. Biotechnol Bioeng. 2000;69:440-449.

   Not in our library10.1002/1097-0290(20000820)69:4<440::aid-bit10>3.0.co;2-0

3. 3.

   Mercille S, Johnson M, Lanthier S, Kamen AA, Massie B. Understanding factors that limit the productivity of suspension-based perfusion cultures operated at high medium renewal rates. Biotechnol Bioeng. 2000;67:435-450.

   Not in our library10.1002/(sici)1097-0290(20000220)67:4<435::aid-bit7>3.0.co;2-y

4. 4.

   Tang YJ, Ohashi R, Hamel J-F. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system. Biotechnol Prog. 2007;23:255-264.

   Not in our library10.1021/bp060299a

5. 5.

   Voisard D, Meuwly F, Ruffieux PA, Baer G, Kadouri A. Potential of cell retention techniques for large-scale high-density perfusion culture of suspended mammalian cells. Biotechnol Bioeng. 2003;82:751-765.

   Not in our library10.1002/bit.10629

6. 6.

   Chotteau V, Björling T, Boork S, Brink-Nilsson H, Chatzissavidou N, Fenge C, Lindner-Olsson E, Olofsson M, Rosenquist J, Sandberg H, Smeds A-L, Drapeau D, Lindner-Olsson E, Chatzissavidou N, Lüllau E. Development of a large scale process for the production of recombinant truncated factor VIII in CHO cells under cell growth arrest conditions. 2001;287-292.

   Not in our library

7. 7.

   Johnson M, Lanthier S, Massie B, Lefebvre G, Kamen AA. Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium. Biotechnol Prog. 1996;12:855-864.

   Not in our library10.1021/bp960072n

8. 8.

   Kompala DS, Ozturk SS, Ozturk SS, Hu W-S. Optimization of high cell density perfusion bioreactors. Cell Culture Technology for Pharmaceutical and Cell-Based Therapies. 2005;387-416.

   Not in our library

9. 9.

   Pinto RC, Medronho RA, Castilho LR. Separation of CHO cells using hydrocyclones. Cytotechnology. 2008;56:57-67.

   Not in our library10.1007/s10616-007-9108-x

10. 10.

    Woodside SM, Bowen BD, Piret JM. Mammalian cell retention devices for stirred perfusion bioreactors. Cytotechnology. 1998;28:163-175.

    Not in our library10.1023/a:1008050202561

11. 11.

    de la Broise D, Noiseux M, Lemieux R, Massie B. Long-term perfusion culture of hybridoma: a "grow or die" cell cycle system. Biotechnol Bioeng. 1991;38:781-787.

    Not in our library10.1002/bit.260380712

12. 12.

    Zhang Y, Stobbe P, Orrego CS, Chotteau V.

    Not in our library

13. 13.

    Caron A, Tom R, Kamen A, Massie B. Baculovirus expression system scaleup by perfusion of high-density Sf-9 cell cultures. Biotechnol Bioeng. 1994;43:881-891.

    Not in our library10.1002/bit.260430907

14. 14.

    Cortin V, Thibault J, Jacob D, Garnier A. High-titer adenovirus vector production in 293S cell perfusion culture. Biotechnol Prog. 2004;20:858-863.

    Not in our library10.1021/bp034237l

15. 15.

    Velez D, Miller L, Macmillan JD. Use of tangential flow filtration in perfusion propagation of hybridoma cells for production of monoclonal-antibodies. Biotechnol Bioeng. 1989;33:938-940.

    Not in our library10.1002/bit.260330721

16. 16.

    Yuk IH, Olsen MM, Geyer S, Forestell SP. Perfusion cultures of human tumor cells: a scalable production platform for oncolytic adenoviral vectors. Biotechnol Bioeng. 2004;86:637-642.

    Not in our library10.1002/bit.20158

17. 17.

    Bleckwenn NA, Golding H, Bentley WE, Shiloach J. Production of recombinant proteins by vaccinia virus in a microcarrier based mammalian cell perfusion bioreactor. Biotechnol. Bioeng. 2005;90:663-674.

    Not in our library10.1002/bit.20423

18. 18.

    Clincke MF, Molleryd C, Zhang Y, Lindskog E, Walsh K, Chotteau V. Study of a recombinant CHO cell line producing a monoclonal antibody by ATF or TFF external filter perfusion in a WAVE Bioreactor. BMC Proc. 2011;5(Suppl. 8):P105.

    Not in our library10.1186/1753-6561-5-s8-p105

19. 19.

    Furey J. Scale-up of a cell culture perfusion process—a low-shear filtration system that inhibits filter-membrane fouling. Genet Eng News. 2002;22:62-62.

    Not in our library

20. 20.

    Singh V. Disposable bioreactor for cell culture using wave-induced agitation. Cytotechnology. 1999;30:149-158.

    Not in our library10.1023/a:1008025016272

21. 21.

    Eibl R, Eibl D. Application of disposable bag bioreactors in tissue engineering and for the production of therapeutic agents. Adv Biochem Eng/Biotechnol. 2009;112:183-207.

    Not in our library10.1007/978-3-540-69357-4_8

22. 22.

    Lim J, Sinclair A. Process economy of disposable manufacturing: process models to minimize upfront investment. Am Pharm Rev. 2007;10:114-121.

    Not in our library

23. 23.

    Kuczewski M, Schirmer E, Lain B, Zarbis-Papastoitsis G. A single-use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line. Biotechnol J. 2011;6:56-65.

    Not in our library10.1002/biot.201000292

24. 24.

    Clincke MF, Molleryd C, Samani PK, Lindskog E, Fäldt E, Walsh K, Chotteau V. Very high density of CHO cells in perfusion by ATF or TFF in WAVE Bioreactor™—Part II. Applications for Antibody Production and Cryopreservation. Biotechnol Prog.

    Not in our library

25. 25.

    Ozturk SS. Engineering challenges in high density cell culture systems. Cytotechnology. 1996;22:3-16.

    Not in our library10.1007/bf00353919

26. 26.

    Chotteau V, Tördal K, Perroud P.

    Not in our library

27. 27.

    Konstantinov K, Goudar C, Ng M, Meneses R, Thrift J, Chuppa S, Matanguihan C, Michaels J, Naveh D. The "push-to-low" approach for optimization of high-density perfusion cultures of animal cells. Adv Biochem Eng/Biotechnol. 2006;101:75-98.

    Not in our library10.1007/10_016

28. 28.

    deZengotita V, Schmelzer A, Miller W. Characterization of hybridoma cell responses to elevated pCO(2) and osmolality: intracellular pH, cell size, apoptosis, and metabolism. Biotechnol Bioeng. 2002;77:369-380.

    Not in our library10.1002/bit.10176

29. 29.

    Kimura R, Miller W. Effects of elevated pCO(2) and/or osmolality on the growth and recombinant tPA production of CHO cells. Biotechnol Bioeng. 1996;52:152-160.

    Not in our library10.1002/(sici)1097-0290(19961005)52:1<152::aid-bit15>3.0.co;2-q

30. 30.

    Takuma S, Hirashima C, Piret JM. Dependence on glucose limitation of the pCO2 influences on CHO cell growth, metabolism and IgG production. Biotechnol Bioeng. 2007;97:1479-1488.

    Not in our library10.1002/bit.21376

31. 31.

    Kyung YS, Peshwa MV, Gryte DM, Hu WS. High density culture of mammalian cells with dynamic perfusion based on on-line oxygen uptake rate measurements. Cytotechnology. 1994;14:183-190.

    Not in our library10.1007/bf00749615

32. 32.

    Adams T, Noack U, Frick T, Greller G, Fenge C. Increasing efficiency in protein and cell production by combining single-use bioreactor technology and perfusion. BioPharm Int Suppl. 2011;24:4-11.

    Not in our library

33. 33.

    Wang L, Hu H, Yang J, Wang F, Kaisermayer C, Zhou P. High yield of human monoclonal antibody produced by stably transfected Drosophila schneider 2 cells in perfusion culture using wave bioreactor. Mol Biotechnol. 2012;52:170-179.

    Not in our library10.1007/s12033-011-9484-5

34. 34.

    Zoro BJ, Owen S, Drake RA, Mason C, Hoare M. Regenerative medicine bioprocessing: concentration and behavior of adherent cell suspensions and pastes. Biotechnol Bioeng. 2009;103:1236-47.

    Not in our library10.1002/bit.22356

35. 35.

    Malinowski JJ, Lafforgue C, Goma G. Rheological behavior of high-density continuous cultures of Saccharomyces cerevisiae. J Ferment Technol. 1987;65:319-323.

    Not in our library

36. 36.

    Reuss M, Josic D, Popovic M, Bronn WK. Viscosity of yeast suspensions. Eur J Appl Microbiol. 1979;8:167-175.

    Not in our library

37. 37.

    Curtis WR, Emery AH. Plant cell suspension culture rheology. Biotechnol Bioeng. 1993;42:520-526.

    Not in our library10.1002/bit.260420416

38. 38.

    Wu L, Ek M, Song M, Sichen D. The effect of solid particles on liquid viscosity. Steel Res Int. 2011;82:388-397.

    Not in our library

39. 39.

    Russotti G, Osawa AE, Sitrin RD, Buckland BC, Adams WR, Lee SS. Pilot-scale harvest of recombinant yeast employing microfiltration: a case study. J Biotechnol. 1995;42:235-246.

    Not in our library10.1016/0168-1656(95)00083-3

40. 40.

    Castilho LR, Medronho RA. Cell retention devices for suspended-cell perfusion cultures. Adv Biochem Eng/Biotechnol. 2002;74:129-169.

    Not in our library10.1007/3-540-45736-4_7

Cited by papers we hold 2

• Scale‐up economics for cultured meat · 2021
  No notice
• Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.